ホーム > 市場調査レポート > 産業用機械

測定機器

市場調査レポート

商品コード

1587080

細菌学的検査市場：細菌タイプ別、検査方法別、成分別、用途別、地域別、機会、予測、2017年～2031年

Bacteriological Testing Market Assessment, By Bacteria Type, By Testing Method, By Component, By Application, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年11月12日
発行: Market Xcel - Markets and Data
ページ情報: 英文 237 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 670,050円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 848,730円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,220,980円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の細菌学的検査の市場規模は、予測期間の2024年～2031年に8.11%のCAGRで拡大し、2023年の155億3,000万米ドルから2031年には289億8,000万米ドルに成長すると予測されています。細菌学的検査の市場需要は、意識の高まりと投資家や市場関係者の関心の高まりにより、予測数年間で飛躍的に成長すると予測されます。

細菌学的検査は、食品サンプル、水サンプル、医薬品サンプル、その他の臨床検体中の細菌を検出・分析し、公衆衛生と安全を確保するために必要です。この市場の原動力は、細菌感染や食中毒に対する健康上の懸念と、政府や保健機関による厳格な規制遵守です。市場は、培地、試薬、キット、機器などの製品タイプに区分され、その使いやすさから人気を集めています。臨床診断、環境検査、食品・飲料の安全、製薬などに応用されています。

細菌感染症とは、有害な細菌や毒素（より具体的には毒素と呼ばれる）の増殖に起因するあらゆる状態や病気を指します。有害な細菌によって引き起こされるこれらの感染症は、環境、感染した個体や動物との接触、または食物、水、表面など汚染されたものを介して感染する可能性があります。例えば、2024年6月、One Health Trustは、細菌感染症は年間推定770万人の死亡を引き起こし、そのうち495万人は抗生物質に耐性を持つ細菌に関連していると報告しています。2024年1月19日、ELITechGroupは体外診断用医薬品のポートフォリオを拡大するため、消化器感染症をターゲットとした細菌病原体パネルのELiTe MGBファーストキットを発売しました。

当レポートでは、世界の細菌学的検査市場について調査し、市場の概要とともに、細菌タイプ別、検査方法別、成分別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

市場リーダートップ5参の競合マトリックス
入企業トップ5参のSWOT分析
市場の主要参入企業トップ10の情勢
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories.
- Merck KGaA.
- HiMedia Laboratories.
- BUREAU VERITAS.
- Agilent Technologies, Inc.
- Intertek Group plc.
- Eiken Chemical Co, Ltd.
- Titan Biotech.
- Eurofins Scientific

第21章戦略的提言

第22章お問い合わせと免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 3. Global Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 4. Global Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 5. Global Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 6. Global Bacteriological Testing Market Share (%), By Region, 2017-2031F
Figure 7. North America Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 8. North America Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 9. North America Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 10. North America Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 11. North America Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 12. North America Bacteriological Testing Market Share (%), By Country, 2017-2031F
Figure 13. United States Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 14. United States Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 15. United States Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 16. United States Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 17. United States Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 18. Canada Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 19. Canada Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 20. Canada Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 21. Canada Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 22. Canada Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 23. Mexico Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 24. Mexico Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 25. Mexico Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 26. Mexico Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 27. Mexico Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 28. Europe Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 29. Europe Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 30. Europe Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 31. Europe Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 32. Europe Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 33. Europe Bacteriological Testing Market Share (%), By Country, 2017-2031F
Figure 34. Germany Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 35. Germany Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 36. Germany Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 37. Germany Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 38. Germany Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 39. France Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 40. France Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 41. France Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 42. France Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 43. France Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 44. Italy Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 45. Italy Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 46. Italy Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 47. Italy Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 48. Italy Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 49. United Kingdom Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 50. United Kingdom Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 51. United Kingdom Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 52. United Kingdom Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 53. United Kingdom Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 54. Russia Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 55. Russia Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 56. Russia Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 57. Russia Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 58. Russia Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 59. Netherlands Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 60. Netherlands Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 61. Netherlands Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 62. Netherlands Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 63. Netherlands Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 64. Spain Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 65. Spain Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 66. Spain Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 67. Spain Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 68. Spain Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 69. Turkey Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 70. Turkey Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 71. Turkey Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 72. Turkey Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 73. Turkey Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 74. Poland Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 75. Poland Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 76. Poland Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 77. Poland Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 78. Poland Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 79. South America Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 80. South America Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 81. South America Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 82. South America Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 83. South America Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 84. South America Bacteriological Testing Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 86. Brazil Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 87. Brazil Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 88. Brazil Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 89. Brazil Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 90. Argentina Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 91. Argentina Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 92. Argentina Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 93. Argentina Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 94. Argentina Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 95. Asia-Pacific Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 96. Asia-Pacific Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 97. Asia-Pacific Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 98. Asia-Pacific Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 99. Asia-Pacific Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 100. Asia-Pacific Bacteriological Testing Market Share (%), By Country, 2017-2031F
Figure 101. India Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 102. India Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 103. India Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 104. India Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 105. India Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 106. China Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 107. China Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 108. China Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 109. China Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 110. China Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 111. Japan Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 112. Japan Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 113. Japan Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 114. Japan Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 115. Japan Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 116. Australia Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 117. Australia Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 118. Australia Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 119. Australia Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 120. Australia Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 121. Vietnam Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 122. Vietnam Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 123. Vietnam Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 124. Vietnam Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 125. Vietnam Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 126. South Korea Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 127. South Korea Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 128. South Korea Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 129. South Korea Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 130. South Korea Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 131. Indonesia Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 132. Indonesia Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 133. Indonesia Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 134. Indonesia Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 135. Indonesia Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 136. Philippines Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 137. Philippines Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 138. Philippines Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 139. Philippines Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 140. Philippines Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 141. Middle East & Africa Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 142. Middle East & Africa Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 143. Middle East & Africa Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 144. Middle East & Africa Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 145. Middle East & Africa Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 146. Middle East & Africa Bacteriological Testing Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 148. Saudi Arabia Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 149. Saudi Arabia Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 150. Saudi Arabia Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 151. Saudi Arabia Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 152. UAE Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 153. UAE Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 154. UAE Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 155. UAE Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 156. UAE Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 157. South Africa Bacteriological Testing Market, By Value, In USD Billion, 2017-2031F
Figure 158. South Africa Bacteriological Testing Market Share (%), By Bacteria Type, 2017-2031F
Figure 159. South Africa Bacteriological Testing Market Share (%), By Testing Method, 2017-2031F
Figure 160. South Africa Bacteriological Testing Market Share (%), By Component, 2017-2031F
Figure 161. South Africa Bacteriological Testing Market Share (%), By Application, 2017-2031F
Figure 162. By Bacteria Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Testing Method Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX12203

Global bacteriological testing market is projected to witness a CAGR of 8.11% during the forecast period 2024-2031, growing from USD 15.53 billion in 2023 to USD 28.98 billion in 2031. The market demand for bacteriological testing is anticipated to thrive drastically in the forecast years due to rising awareness and the growing interest of investors and market players.

Bacteriological testing is necessary for detecting and analyzing bacteria in food samples, water samples, pharmaceutical samples, and other clinical specimens, thereby ensuring public health and safety. The driving forces for this market are health concerns over bacterial infections and foodborne diseases and strict regulatory compliance from governments and health organizations. The market is segmented into different product types, such as culture media, reagents, kits, and equipment, gaining popularity due to their ease of use. Applications exist in clinical diagnostics, environmental testing, food and beverage safety, and pharmaceutical applications. Bacterial infection refers to any condition or disease coming from the growth of harmful bacteria or poisons, more specifically called toxins. Those infections caused by harmful bacteria can be acquired through contact with the environment, an infected individual or animal, or through something contaminated such as food, water, or surfaces. For instance, in June 2024, One Health Trust reported that Bacterial infections cause an estimated 7.7 million deaths annually, 4.95 million of which are associated with bacteria resistant to antibiotics. On 19 January 2024, ELITechGroup launched their ELiTe MGB first kit of the bacterial pathogens panel targeting gastrointestinal infection, to expand its in vitro diagnostic portfolio.

Increased Prevalence of Bacterial Infections to Drive Market Growth

The increased prevalence of bacterial infections is a significant factor leading to the growth of the market for bacteriological testing. The need for diagnostic testing is becoming more demanding. The surge in gastrointestinal infections has been a result of urbanization and changing lifestyles that resulted in the development of infectious diseases, such as tuberculosis and MRSA infections. This growing burden of bacterial infections requires rapid and accurate diagnosis to treat and control outbreaks quickly. Thus, with healthcare providers and policymakers becoming increasingly aware of these emergencies, the necessity for bacteriological testing is increasing so as to bring attention to diagnostics in public health management. Another reason this market faces an increased demand for bacteriological testing is due to frequent outbursts of foodborne illnesses caused by bacteria such as salmonella, E. coli, and legionella. For instance, in December 2023, HiMedia-HiGenoMB joined a collaboration with NG Biotech, a France-based company, after the Central Drugs Standard Control Organization (CDSCO) approved for importing an NG-Test CARBA 5 kit from NG Biotech. The kit is a rapid test for the qualitative detection and differentiation of five common carbapenemase enzymes (KPC (K), OXA-48-like (O), IMP (I), VIM (V), NDM (N)) in bacterial colonies.

Increasing Health and Safety Awareness and Advancement in Technology to Drive Market Growth

The bacteriological testing market is driven by increasing health and safety awareness. Increasing consciousness about hygiene and contamination risks among consumers and organizations creates a high demand for micro-organism security of food, water, and healthcare. High concern generated by this increased awareness leads to increased demand for reliable bacteriological testing to ensure product standards and protect public health. Educational campaigns and changes in regulations bring better emphasis to regular testing, making businesses and laboratories operate on more stringent testing practices. Advancements in bacteriological testing, have transformed the market with tremendous improvements in diagnostic accuracy, speed, and efficiency. For instance, this technology development in polymerase chain reaction (PCR) and next-generation sequencing mechanisms could enable quicker identification of bacterial pathogens in simple and complex samples with the possibility of accelerated decision-making in clinical and environmental setups. As technology continues to advance, the bacteriological testing market is ripe for future growth. For instance on 29 January 2024, Charles River Laboratories International, Inc. launched the First Rapid Animal-Free Bacterial Endotoxin Test, the Endosafe Trillium recombinant cascade reagent (rCR), expanding its robust bacterial endotoxin testing (BET) portfolio.

Food and Beverage Testing Segment to Dominate the Bacteriological Testing Market Share

The food and beverage testing segment is expected to dominate the share of the global bacteriological testing market. Rising consumer awareness about food safety and quality is driving the increasing demand in this sector. With the increasing incidence of foodborne illnesses and increased regulatory requirements, food manufacturers are adopting microbiological testing as a significant measure to render their products free from harmful pathogens. This segment encompasses a spectrum of testing methodologies, ranging from elementary observations and sampling to highly sophisticated molecular methods that yield quick and reliable responses. Additionally, increased openness about food sources and production chains has become the norm, putting more pressure on companies to be more stringent in testing procedures, and thus, the demand for bacteriological test products has soared due to this reason. This segment is likely to grow and become a leader in the market.

According to the National Centre for Disease Control Data, in March 2024, food poisoning and diarrhea are increasingly more prevalent. Food Safety and Standards Authority of India (FSSAI) is working to establish a network of 34 microbiology labs across the country, all of which would be equipped to test food products for ten pathogens, including E. coli, Salmonella, and Listeria.

North America to Dominate Bacteriological Testing Market Share

North America is anticipated to dominate the share of the bacteriological testing market due to several factors, such as the high prevalence of bacterial infections and advancements in technology. For instance, in November 2023, according to the Centers for Disease Control and Prevention (CDC), at least 2.8 million people in the United States get antibiotic-resistant infections each year, and more than 35,000 die from these infections. The presence of key players in the biotechnology and diagnostics segments, along with significant investments in R&D have propelled market growth. As consumers increasingly focus their attention on health and safety, the trend for accurate and rapid testing solutions is bound to sustain the leadership North America maintains in the global bacteriological testing landscape. For instance, in June 2024, QIAGEN announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the United States. The launch comes after recent clearance by the FDA, after which the syndromic test was granted approval for its clinical use, an important advancement in improving the efficiency and accuracy of gastrointestinal (GI) infection diagnosis.

Future Market Scenario (2024-2031F)

The future market scenario of the bacteriological testing market is poised for significant growth, driven by increased awareness and prevalence of infectious diseases and advancement in testing technology. Innovations such as rapid testing methods, automation, and artificial intelligence have improved bacteriological assays' accuracy and efficiency, making them accessible to many sectors, including healthcare, food safety, and environmental monitoring. Also, the growing threat of antimicrobial resistance and the development of personalized medicine create greater demand for advanced testing capabilities. Increasingly stringent regulatory guidelines and shifts in global health threats will ensure considerable growth in the demand for bacteriological testing. The work will be driven by emergent markets. It is a vision of new methodologies for testing and expanding markets that can capture and benefit from public health around the world. For instance, in February 2024, Charles River Laboratories., a microbial solutions company based in the United States, expanded its bacterial endotoxin testing (BET) portfolio with a new animal-free solution, building on its Trillium rCR product. The pre-loaded rCR cartridges simplify testing by removing the need for multiple reagent preparations, offering faster, accurate results while reducing technician error.

Key Players Landscape and Outlook

The bacteriological testing market is highly competitive, with numerous key players driving growth through strategic business agreements, collaborations, and regulatory product approvals. In recent years, there has been a significant increase in activities, reinforcing the market's dynamic nature. Additionally, smaller companies contribute to the market landscape by engaging in partnerships with established players. This collaborative approach enables the industry to meet the evolving needs of various end-users efficiently and maintain a robust market presence.

For instance, in September 2024, LuminUltra Technologies Ltd. expanded its molecular testing portfolio by acquiring the Legionella testing business assets of Genomadix Inc. This strategic acquisition enhances LuminUltra Technologies Ltd.'s capabilities in rapid identification and quantification of Legionella microbes across residential, commercial, and industrial water systems, reinforcing its position in water quality monitoring solutions.

In June 2022, STEMart Inc. launched microbiology & sterility testing services for medical devices, offering expertise to help manufacturers meet regulatory standards and reduce compliance risks through a full-service and end-to-end solution.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bacteriological Testing Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Bacteria Type
  - 4.2.1.1. Salmonella
  - 4.2.1.2. Legionella
  - 4.2.1.3. Listeria
  - 4.2.1.4. Campylobacter
  - 4.2.1.5. Coliform
  - 4.2.1.6. Others
- 4.2.2. By Testing Method
  - 4.2.2.1. Conventional Methods
  - 4.2.2.2. Quick Detection Technique
- 4.2.3. By Component
  - 4.2.3.1. Instruments
  - 4.2.3.2. Test Kits
  - 4.2.3.3. Consumables and Reagents
- 4.2.4. By Application
  - 4.2.4.1. Food and Beverages
  - 4.2.4.2. Water
  - 4.2.4.3. Pharmaceuticals
  - 4.2.4.4. Others
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Bacteria Type
- 4.3.2. By Testing Method
- 4.3.3. By Component
- 4.3.4. By Application
- 4.3.5. By Region

5. North Bacteriological Testing Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Bacteria Type
  - 5.2.1.1. Salmonella
  - 5.2.1.2. Legionella
  - 5.2.1.3. Listeria
  - 5.2.1.4. Campylobacter
  - 5.2.1.5. Coliform
  - 5.2.1.6. Others
- 5.2.2. By Testing Method
  - 5.2.2.1. Conventional Methods
  - 5.2.2.2. Quick Detection Technique
- 5.2.3. By Component
  - 5.2.3.1. Instruments
  - 5.2.3.2. Test Kits
  - 5.2.3.3. Consumables and Reagents
- 5.2.4. By Application
  - 5.2.4.1. Food and Beverages
  - 5.2.4.2. Water
  - 5.2.4.3. Pharmaceuticals
  - 5.2.4.4. Others
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Bacteriological Testing Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Bacteria Type
      - 5.3.1.2.1.1. Salmonella
      - 5.3.1.2.1.2. Legionella
      - 5.3.1.2.1.3. Listeria
      - 5.3.1.2.1.4. Campylobacter
      - 5.3.1.2.1.5. Coliform
      - 5.3.1.2.1.6. Others
    - 5.3.1.2.2. By Testing Method
      - 5.3.1.2.2.1. Conventional Methods
      - 5.3.1.2.2.2. Quick Detection Technique
    - 5.3.1.2.3. By Component
      - 5.3.1.2.3.1. Instruments
      - 5.3.1.2.3.2. Test Kits
      - 5.3.1.2.3.3. Consumables and Reagents
    - 5.3.1.2.4. By Application
      - 5.3.1.2.4.1. Food and Beverages
      - 5.3.1.2.4.2. Water
      - 5.3.1.2.4.3. Pharmaceuticals
      - 5.3.1.2.4.4. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Bacteriological Testing Market Outlook, 2017-2031F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Bacteriological Testing Market Outlook, 2017-2031F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Bacteriological Testing Market Outlook, 2017-2031F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Bacteriological Testing Market Outlook, 2017-2031F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

17.1. Clinical Trials
17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

20.1. Competition Matrix of Top 5 Market Leaders
20.2. SWOT Analysis for Top 5 Players
20.3. Key Players Landscape for Top 10 Market Players
- 20.3.1. Thermo Fisher Scientific, Inc.
  - 20.3.1.1. Company Details
  - 20.3.1.2. Key Management Personnel
  - 20.3.1.3. Products and Services
  - 20.3.1.4. Financials (As Reported)
  - 20.3.1.5. Key Market Focus and Geographical Presence
  - 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 20.3.2. Bio-Rad Laboratories.
- 20.3.3. Merck KGaA.
- 20.3.4. HiMedia Laboratories.
- 20.3.5. BUREAU VERITAS.
- 20.3.6. Agilent Technologies, Inc.
- 20.3.7. Intertek Group plc.
- 20.3.8. Eiken Chemical Co, Ltd.
- 20.3.9. Titan Biotech.
- 20.3.10. Eurofins Scientific.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

ライセンス / 価格

PDF & Excel Printable (Single User License)

USD 4,500 670,050円

その他のライセンス / 価格

PDF & Excel Printable (Corporate License)

USD 5,700 848,730円

PDF & Excel Printable (Custom Research License)

USD 8,200 1,220,980円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

細菌検査

細菌学的検査市場：細菌タイプ別、検査方法別、成分別、用途別、地域別、機会、予測、2017年～2031年

Bacteriological Testing Market Assessment, By Bacteria Type, By Testing Method, By Component, By Application, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の細菌学的検査市場の見通し、2017年～2031年

第5章 北米の細菌学的検査市場の見通し、2017年～2031年

第6章 欧州の細菌学的検査市場の見通し、2017年～2031年

第7章 アジア太平洋の細菌学的検査市場の見通し、2017年～2031年

第8章 南米の細菌学的検査市場の見通し、2017年～2031年

第9章 中東・アフリカの細菌学的検査市場の見通し、2017年～2031年

第10章 需要供給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

第18章 特許の情勢

第19章 ケーススタディ

第20章 競合情勢

第21章 戦略的提言

第22章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bacteriological Testing Market Outlook, 2017-2031F

5. North Bacteriological Testing Market Outlook, 2017-2031F*

6. Europe Bacteriological Testing Market Outlook, 2017-2031F

7. Asia-Pacific Bacteriological Testing Market Outlook, 2017-2031F

8. South America Bacteriological Testing Market Outlook, 2017-2031F

9. Middle East and Africa Bacteriological Testing Market Outlook, 2017-2031F

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

16. Market Trends and Developments

17. Regulatory Framework and Innovation

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

21. Strategic Recommendations

22. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章世界の細菌学的検査市場の見通し、2017年～2031年

第5章北米の細菌学的検査市場の見通し、2017年～2031年

第6章欧州の細菌学的検査市場の見通し、2017年～2031年

第7章アジア太平洋の細菌学的検査市場の見通し、2017年～2031年

第8章南米の細菌学的検査市場の見通し、2017年～2031年

第9章中東・アフリカの細菌学的検査市場の見通し、2017年～2031年

第10章需要供給分析

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第14章価格分析

第15章市場力学

第16章市場の動向と発展

第17章規制枠組みとイノベーション

第18章特許の情勢

第19章ケーススタディ

第20章競合情勢

第21章戦略的提言

第22章お問い合わせと免責事項